πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 308 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7662394

Nucleic acids encoding chimeric Flavivirus immunogens comprising the Japanese encephalitis

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7632508

Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines

The United States of America Β· Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7622123

Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7578998

Chimeric cytokine of IL-7 and beta-chain of HGF and methods of use

UNIVERSITY OF CONNECTICUT Β· Granted Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7569542

Anti-microbial targeting chimeric pharmaceutical

The Regents of the University of California Β· Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7541040

Chimeric molecule for the treatment of th2-like cytokine mediated disorders

The United States of America as represented by the Department of Health and Human Serivces Β· Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7524944

Chimeric nucleic acids encoding polypeptides comprising CD154 and TNF-Ξ±

The Regents of the University of California Β· Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7524499

Modified chimeric polypeptides with improved pharmacokinetic properties

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7521211

IGF-1 and IGF-2 chimeric polypeptides and therapeutic uses thereof

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7517531

Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3β€²-UTR of den

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7495090

Nucleic acids encoding chimeric CD154 polypeptides

The Regents of the University of California Β· Granted Tue Feb 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7473772

Chimeric GB virus B (GBV-B)

The Board of Regents of the University of Texas System Β· Granted Tue Jan 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7462356

Chimeric papillomavirus-like particles

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7404956

Immunoglobulin chimeric monomer-dimer hybrids

Syntonix Pharmaceuticals, Inc. Β· Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7393833

Chimeric proteins with phosphatidylserine binding domains

The Board of Regents of the University of Oklahoma Β· Granted Tue Jul 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 26 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7381408

Methods for chemically synthesizing immunoglobulin chimeric proteins

Syntonix Pharmaceuticals, Inc. Β· Granted Tue Jun 03 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7374758

Modified chimeric polypeptides with improved pharmacokinetic properties and methods of usi

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7374757

Modified chimeric polypeptides with improved pharmacokinetic properties

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7348004

Immunoglobulin chimeric monomer-dimer hybrids

Syntonix Pharmaceuticals, Inc. Β· Granted Tue Mar 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7314632

Pseudomonas exotoxin A-like chimeric immunogens

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7314625

Chimeric protein comprising non-toxic Pseudomonas exotoxin A and Type IV pilin sequences

The United States as represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7303746

Methods of treating eye disorders with modified chimeric polypeptides

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Dec 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7267978

Chimeric transcriptional regulatory element compositions and methods for increasing prosta

The Regents of the University of California Β· Granted Tue Sep 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7250171

Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprote

The United States of America as represented by the Secretary of the Dept. of Health & Human Services Β· Granted Tue Jul 31 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted